These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 34655417)

  • 21. Biofluid quantification of TWEAK/Fn14 axis in combination with a selected biomarker panel improves assessment of prostate cancer aggressiveness.
    Ruiz-Plazas X; Rodríguez-Gallego E; Alves M; Altuna-Coy A; Lozano-Bartolomé J; Portero-Otin M; García-Fontgivell JF; Martínez-González S; Segarra J; Chacón MR
    J Transl Med; 2019 Sep; 17(1):307. PubMed ID: 31500625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood-based and urinary prostate cancer biomarkers: a review and comparison of novel biomarkers for detection and treatment decisions.
    Hendriks RJ; van Oort IM; Schalken JA
    Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):12-19. PubMed ID: 27922627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate cancer: Novel genetic and immunologic biomarkers.
    Samare-Najaf M; Kouchaki H; Moein Mahini S; Saberi Rounkian M; Tavakoli Y; Samareh A; Karim Azadbakht M; Jamali N
    Clin Chim Acta; 2024 Mar; 555():117824. PubMed ID: 38316287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current state of biomarkers for the diagnosis and assessment of treatment efficacy of prostate cancer.
    Liu J; Li Y; Yang D; Yang C; Mao L
    Discov Med; 2019 Jun; 27(150):235-243. PubMed ID: 31421692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel algorithm for the prediction of prostate cancer in clinically suspected patients.
    Gallotta A; Ziglioli F; Ferretti S; Maestroni U; Moretti M; Aloe R; Gnocchi C; Di Palo M; Fassina G
    Cancer Biomark; 2013; 13(4):227-34. PubMed ID: 24240583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiplexed quantitative proteomics in prostate cancer biomarker development.
    Gao Y; Kim H; Kitata RB; Lin TT; Swensen AC; Shi T; Liu T
    Adv Cancer Res; 2024; 161():31-69. PubMed ID: 39032952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study of glycosylation of prostate-specific antigen secreted by cancer tissue-originated spheroids reveals new candidates for prostate cancer detection.
    Ideo H; Kondo J; Nomura T; Nonomura N; Inoue M; Amano J
    Sci Rep; 2020 Feb; 10(1):2708. PubMed ID: 32066783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentially expressed androgen-regulated genes in androgen-sensitive tissues reveal potential biomarkers of early prostate cancer.
    Altintas DM; Allioli N; Decaussin M; de Bernard S; Ruffion A; Samarut J; Vlaeminck-Guillem V
    PLoS One; 2013; 8(6):e66278. PubMed ID: 23840433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical utility of emerging biomarkers in prostate cancer liquid biopsies.
    Boerrigter E; Groen LN; Van Erp NP; Verhaegh GW; Schalken JA
    Expert Rev Mol Diagn; 2020 Feb; 20(2):219-230. PubMed ID: 31577907
    [No Abstract]   [Full Text] [Related]  

  • 30. Translational Research for Identifying Potential Early-stage Prostate Cancer Biomarkers.
    Nakamura N; Rogers P; Eggerson R; Post SR; Davis R
    Cancer Genomics Proteomics; 2023; 20(1):1-8. PubMed ID: 36581341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The C-terminal fragment of prostate-specific antigen, a 2331 Da peptide, as a new urinary pathognomonic biomarker candidate for diagnosing prostate cancer.
    Nakayama K; Inoue T; Sekiya S; Terada N; Miyazaki Y; Goto T; Kajihara S; Kawabata S; Iwamoto S; Ikawa K; Oosaga J; Tsuji H; Tanaka K; Ogawa O
    PLoS One; 2014; 9(9):e107234. PubMed ID: 25233230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary Prostate Cancer Antigen 3 as a Tumour Marker: Biochemical and Clinical Aspects.
    Schmid M; Hansen J; Chun FK
    Adv Exp Med Biol; 2015; 867():277-89. PubMed ID: 26530372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structure of human prostate-specific antigen in a sandwich antibody complex.
    Stura EA; Muller BH; Bossus M; Michel S; Jolivet-Reynaud C; Ducancel F
    J Mol Biol; 2011 Dec; 414(4):530-44. PubMed ID: 22037582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in biomarkers for the early diagnosis of prostate cancer.
    Cao DL; Yao XD
    Chin J Cancer; 2010 Feb; 29(2):229-33. PubMed ID: 20109357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic and predictive biomarkers in prostate cancer.
    Kontos CK; Adamopoulos PG; Scorilas A
    Expert Rev Mol Diagn; 2015; 15(12):1567-76. PubMed ID: 26548550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The utility of PSA velocity in prediction of prostate cancer and high grade cancer after an initially negative prostate biopsy.
    Elshafei A; Li YH; Hatem A; Moussa AS; Ethan V; Krishnan N; Li J; Jones JS
    Prostate; 2013 Dec; 73(16):1796-802. PubMed ID: 24038200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycomics of prostate cancer: updates.
    Tkac J; Bertok T; Hires M; Jane E; Lorencova L; Kasak P
    Expert Rev Proteomics; 2019 Jan; 16(1):65-76. PubMed ID: 30451032
    [No Abstract]   [Full Text] [Related]  

  • 38. Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer.
    Katafigiotis I; Tyritzis SI; Stravodimos KG; Alamanis C; Pavlakis K; Vlahou A; Makridakis M; Katafigioti A; Garbis SD; Constantinides CA
    BJU Int; 2012 Dec; 110(11 Pt B):E688-93. PubMed ID: 23020913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seminal plasma microRNAs improve diagnosis/prognosis of prostate cancer in men with moderately altered prostate-specific antigen.
    Barceló M; Castells M; Pérez-Riba M; Bassas L; Vigués F; Larriba S
    Am J Transl Res; 2020; 12(5):2041-2051. PubMed ID: 32509198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.
    Salido-Guadarrama AI; Morales-Montor JG; Rangel-Escareño C; Langley E; Peralta-Zaragoza O; Cruz Colin JL; Rodriguez-Dorantes M
    Mol Med Rep; 2016 Jun; 13(6):4549-60. PubMed ID: 27081843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.